The Dividend Yield as of December 2025 (TTM) for NovaBay Pharmaceuticals, Inc. (NBY) is 73.39%

According to NovaBay Pharmaceuticals, Inc.’s latest financial reports and current stock price. The company's current Dividend Yield is 73.39%. This represents a change of Infinity% compared to the average of 0% of the last 4 quarters.

NovaBay Pharmaceuticals, Inc. (NBY) Historical Dividend Yield (quarterly & annually)

How has NBY Dividend Yield performed in the past?

The mean historical Dividend Yield of NovaBay Pharmaceuticals, Inc. over the last ten years is 0%. The current 73.39% Dividend Yield has changed Infinity% with respect to the historical average. Over the past ten years (40 quarters), NBY's Dividend Yield was at its highest in in the September 2015 quarter at 0%. The Dividend Yield was at its lowest in in the September 2015 quarter at 0%.

NovaBay Pharmaceuticals, Inc. (NBY) Dividend Yield by Quarter and Year

Discovering the peaks and valleys of NovaBay Pharmaceuticals, Inc. Dividend Yield, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

NovaBay Pharmaceuticals, Inc. (NBY) Average Dividend Yield

How has NBY Dividend Yield performed in the past?

The current Dividend Yield of NovaBay Pharmaceuticals, Inc. (NBY) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

NovaBay Pharmaceuticals, Inc. (NBY) Dividend Yield vs. Peers

How is NBY’s Dividend Yield compared to its peers?

NovaBay Pharmaceuticals, Inc.’s Dividend Yield is greater than Quoin Pharmaceuticals, Ltd. (0%), greater than Impact BioMedical Inc. (0%), greater than Pasithea Therapeutics Corp. (0%), greater than Radiopharm Theranostics Limited (0%), greater than Addex Therapeutics Ltd (0%), greater than Matinas BioPharma Holdings, Inc. (0%), greater than PharmaCyte Biotech, Inc. (0%), greater than Alaunos Therapeutics, Inc. (0%), greater than VivoSim Labs, Inc. (0%), greater than VYNE Therapeutics Inc. (0%),

Build a custom stock screener for NovaBay Pharmaceuticals, Inc. (NBY) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like NovaBay Pharmaceuticals, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

NovaBay Pharmaceuticals, Inc. (NBY) and other stocks custom spreadsheet templates

The easiest way to analyze a company like NovaBay Pharmaceuticals, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.